跳至主要内容
临床试验/NCT06180473
NCT06180473已完成不适用

Evaluation of Tolerability, Efficacy and Adherence to Treatment With Wynzora Cream in Patients With Psoriasis Previously Treated With Enstilar Foam.

Fondazione Policlinico Universitario Agostino Gemelli IRCCS1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2024年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
30
试验地点
1
主要终点
preference of wynzora cream

研究概览

简要总结

The primary objective is to assess with the PPQ questionnaire the patient preference for Wynzora compared with therapy carried out previously with Enstilar spray foam. Secondary objectives Assess satisfaction with the treatment. Assess adherence to therapy. Evaluate the impact of various clinical and demographic factors on treatment adherence. Evaluate the efficacy of Wynzora cream therapy.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients older than 18 years of age, of either sex;
  • Patients diagnosed with mild-to-moderate psoriasis (PASI and BSA <10) requiring monotherapy topical with Wynzora;
  • Patients who have stopped treatment with Enstilar foam for any reason for at least 30 days; and
  • Patients whose medical records are accessible and record all demographic parameters, anthropometric and clinical parameters during the treatment period
  • Signature of written informed consent;

排除标准

  • Patients with palmoplantar, inverse, erythrodermic, guttate, and scalp psoriasis.
  • Patients who are taking concomitant systemic therapies for psoriasis, such as. cyclosporine, methotrexate, acitretin, phototherapy or biologic therapies.
  • Women who are pregnant or planning to become pregnant.
  • Patients with disabilities or other motor problems that could complicate self-medication.

结局指标

主要结局

preference of wynzora cream

时间窗: 1 month

Percentage of patients who prefer treatment with Wynzora compared with treatment with Enstilar at week 4 of use; preference for Wynzora will be assessed by considering a score of 3 or higher on question 5 of the PPQ questionnaire.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Evaluation of Tolerability, Efficacy and Adherence... | 临床试验